English– tag –
-
NBHL will participate in BIO-Europe Spring 2022 – Digital.
NBHL will participate in BIO-Europe Spring 2022 – Digital to be held from Ma... -
Closing of the Series C funding to advance pipeline of novel GPCR antibodies
NBHL has closed the Series C funding to advance pipeline of novel GPCR antibo... -
Announcement of Agreements with ReCentrics Biotechnology Co. Ltd. and NBHL for Global Collaboration to Development and Commercialize GPCR Antibody Therapies
NBHL has singed the Agreements with ReCentrics Biotechnology Co. Ltd. and NBH...
